Nanoparticle-Based Combination Therapy Enhances Fulvestrant Efficacy and Overcomes Tumor Resistance in ER-Positive Breast Cancer

Bozhao  Li; Feilong  Qi; Fei Zhu; Zefang  Lu; Meiqi  Wang; Tianjiao  Chu; Suying  Wu; Jingyan  Wei; Zhenchuan  Song; Saraswati  Sukumar; Cheng  Zhang; Jiangfei  Xu; Suping  Li; Guangjun  Nie

doi:10.1158/0008-5472.CAN-22-3559

Nanoparticle-Based Combination Therapy Enhances Fulvestrant Efficacy and Overcomes Tumor Resistance in ER-Positive Breast Cancer

Bozhao Li, Feilong Qi, Fei Zhu, Zefang Lu, Meiqi Wang, Tianjiao Chu, Suying Wu, Jingyan Wei, Zhenchuan Song, Saraswati Sukumar, Cheng Zhang, Jiangfei Xu, Suping Li, Guangjun Nie

AoPHA Faculty

Research output: Contribution to journal › Article › peer-review

7 Citations (Scopus)

Original language	English
Journal	Cancer Research
DOIs	https://doi.org/10.1158/0008-5472.CAN-22-3559
Publication status	Published - 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1158/0008-5472.CAN-22-3559

Cite this

@article{7992ea6c7a2f43769db63e5f9f07baf8,

title = "Nanoparticle-Based Combination Therapy Enhances Fulvestrant Efficacy and Overcomes Tumor Resistance in ER-Positive Breast Cancer",

author = "Bozhao Li and Feilong Qi and Fei Zhu and Zefang Lu and Meiqi Wang and Tianjiao Chu and Suying Wu and Jingyan Wei and Zhenchuan Song and Saraswati Sukumar and Cheng Zhang and Jiangfei Xu and Suping Li and Guangjun Nie",

year = "2023",

doi = "10.1158/0008-5472.CAN-22-3559",

language = "English",

journal = "Cancer Research",

issn = "0008-5472",

}

TY - JOUR

T1 - Nanoparticle-Based Combination Therapy Enhances Fulvestrant Efficacy and Overcomes Tumor Resistance in ER-Positive Breast Cancer

AU - Li, Bozhao

AU - Qi, Feilong

AU - Zhu, Fei

AU - Lu, Zefang

AU - Wang, Meiqi

AU - Chu, Tianjiao

AU - Wu, Suying

AU - Wei, Jingyan

AU - Song, Zhenchuan

AU - Sukumar, Saraswati

AU - Zhang, Cheng

AU - Xu, Jiangfei

AU - Li, Suping

AU - Nie, Guangjun

PY - 2023

Y1 - 2023

U2 - 10.1158/0008-5472.CAN-22-3559

DO - 10.1158/0008-5472.CAN-22-3559

M3 - Article

C2 - 37326467

SN - 0008-5472

JO - Cancer Research

JF - Cancer Research

ER -